Ro

@serenawilliams is on Ro! There are few people in the world with more willpower than Serena. She trained hard after having kids but her body didn’t respond the same way. She turned to Ro to reach her goals. youtube.com/watch?v=_MAYsc…

We’re making our Super Bowl debut next week—featuring @serenawilliams. In the ad, Serena shares how being on Ro has helped her feel her best, with the benefits she’s experienced going well beyond weight loss, including less joint stress and steady blood sugar. Here’s a first look at the ad. Serena’s healthier on Ro. Supported on Ro.

Ro is collaborating with @Amgen to study insurance coverage of GLP-1s. Our joint research will spotlight which patients have coverage, where gaps in coverage exist, and how to expand access to treatment as the next generation of GLP-1s come to market. ro.co/press/amgen-co…

.@Ro has launched a new GLP-1 pill in partnership with Novo Nordisk. CEO @ZReitano on how the pill will "usher in a new era of digital health": "It's the first time a drug of this size and scale launches nationwide on Ro, so someone can see an ad and go from diagnosis to delivery in 48 hours or less."

Novo Nordisk's Wegovy pill is launching direct-to-consumer with @ro CEO @ZReitano breaks down what the launch means for patients, his company's partnership with $NVO, and more cnb.cx/4aSUKJP

Introducing the Wegovy pill—launched on Ro. By working directly with @novonordisk , we are giving patients nationwide access to this innovative new treatment Day 1 and with seamless delivery to their doors at the best cash price. ro.co/press/wegovy-p…

Patients come to Ro to reach their health goals—and our study in Obesity (@ObesitySociety) shows that they’re successful. Weight loss and safety outcomes were consistent with those in semaglutide clinical trials, losing 16.6% of their weight in 68 weeks. ro.co/press/68-week-…

Can ‘food noise’ be measured? Telehealth giant Ro rolls out a new scale for obesity care trib.al/02YYtOf

Serena Williams has been taking a GLP-1 medication to help with her recent weight loss, she revealed for the first time in an exclusive TODAY interview. today.com/health/womens-…

Affordability = access. By working with Novo Nordisk, starting today through Ro, patients can get their first month of FDA-approved Wegovy® for $199 plus their first month of the Ro Body membership for just $45.

Curious if your insurance covers GLP-1s? Ro’s Insurance Coverage Checker has helped hundreds of thousands. Now, we're revealing key insights in our new report on GLP-1 access. Read the full report: ro.co/weight-loss/co…

Some *BIG* news from the team @ro today — we're thrilled to announce a new partnership with the one and only Charles Barkley! 🏀 As we got to know Charles through this process, it became clear how personally meaningful this subject is to him — even beyond his own weight loss journey. Charles has seen firsthand how powerful GLP-1 therapies can be as a tool for improving health, and he’s passionate about increasing awareness and access to these treatments, especially in underserved communities. We're proud to support Charles on his own health journey and to share his story — along with his signature humor and candor — through this partnership. Huge thanks to the many talented colleagues and partners involved in bring this incredible collaboration to life. We’re just getting started!

A new deal between @Ro and $NVO allows patients to get its flagship weight loss drug Wegovy for as low as $499 per month CEO @ZReitano breaks down the details of the deal and what it means for patients cnb.cx/4jvFofs

Today, @ro is announcing a collaboration with @novonordisk — starting with an integration with NovoCare® Pharmacy. Fighting for patients means making it as easy and affordable as possible to access high-quality treatment, and that’s what Ro and Novo aim to do.

$LLY lowering the price of the vials! $349 for 2.5 and $499 for higher doses on monthly orders. Big win for patients! Also… they’re in stock (always have been since launch). Proud to offer seamless access via @Ro in unique integration with @EliLillyandCo

Ro is working with @EliLillyandCo! Through a first-of-its-kind integration with LillyDirect, Zepbound single-dose vials are now available through Ro – offering a seamless obesity care experience bringing together telehealth, lab, and pharmacy services. cnbc.com/2024/12/11/ro-…

1/ @Ro is empowering patients and providers with world class technology to achieve life-changing outcomes. endpts.com/ros-weight-los… ➡️ Avg weight loss: 15.8% after 12 months on GLP-1s ➡️ 80% of patients with metabolic risks improved their lab results

@bykevinclark @AdamSchefter Work hard, play hard king 👑

I asked @AdamSchefter the weirdest place he's ever broken a story. I cannot possibly recommend this clip more. "I got the job done, Kevin, in every which way."

Patients come to Ro for the care they need to live happier, more fulfilled lives. Today, we’re sharing research highlighting the many ways accessing obesity care through Ro can change lives: ro.co/weight-loss/qu…